Clinical trial
Efficacy and Tolerance Comparison Between Subconjunctival Injection of Triamcinolone and Intravitreal Implant of Dexamethasone for the Treatment of Inflammatory Macular Edema
NCT02556424 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Tolerance Comparison Between Subconjunctival Injection of Triamcinolone and Intravitreal Implant of Dexamethasone for the Treatment of Inflammatory Macular Edema
- Lead sponsor
- Nantes University Hospital
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 31, 2016
- Completion date
- February 15, 2021
- Enrollment
- 114 (actual)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.
inflammatory macular edema